ANPCY / ANGLE's Parsortix used to analyse and inform treatment for aggressive form of breast cancer

ANGLE plc, a leading company in liquid biopsy technology, has unveiled promising research findings that could help transform the treatment of head and more_horizontal

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the liquid biopsy and cancer diagnostics specialist, has hailed a study that could change the way doctors monitor a more_horizontal

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), a specialist in liquid biopsy and circulating tumour cell (CTC) diagnostics, said that nine posters featuring its gr more_horizontal

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), a specialist in liquid biopsies for cancer detection, is showing early signs of progress despite industry headwinds. more_horizontal

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the liquid biopsy company specialising in circulating tumour cell (CTC) diagnostic solutions, anticipates continue more_horizontal

ANGLE plc, a frontrunner in liquid biopsy technology, has unveiled its latest innovation, the Portrait Flex CTC assay - a cutting-edge diagnostic tool more_horizontal

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the developer of the Parsortix liquid biopsy, has enhanced its executive roster with two key appointments: Brett Swa more_horizontal

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), a pioneer of liquid biopsy technology, announced a significant contract win with Artios Pharma. Under the deal ANG more_horizontal